$384 Million is the total value of Endurant Capital Management LP's 61 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 90.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KIDS | Buy | ORTHOPEDIATRICS CORP | $19,313,000 | +142.6% | 396,162 | +105.3% | 5.04% | +75.4% |
| New | INVACARE CORPnote 5.000%11/1 | $19,311,000 | – | 19,966,000 | +100.0% | 5.04% | – | |
| ATNM | New | ACTINIUM PHARMACEUTICALS INCcall | $15,240,000 | – | 2,000,000 | +100.0% | 3.97% | – |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $14,766,000 | -2.5% | 233,898 | -4.2% | 3.85% | -29.5% |
| AHCO | Buy | ADAPTHEALTH CORP | $14,694,000 | +160.1% | 399,730 | +165.8% | 3.83% | +88.0% |
| SNY | New | SANOFIsponsored adr | $13,464,000 | – | 272,218 | +100.0% | 3.51% | – |
| BDX | Sell | BECTON DICKINSON & CO | $13,216,000 | -23.7% | 54,355 | -21.5% | 3.45% | -44.9% |
| CVS | New | CVS HEALTH CORP | $12,591,000 | – | 167,362 | +100.0% | 3.28% | – |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $11,838,000 | +316.2% | 238,099 | +318.5% | 3.09% | +200.9% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $11,533,000 | +185.7% | 45,224 | +128.0% | 3.01% | +106.5% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $11,476,000 | +57.4% | 455,385 | -59.6% | 2.99% | +13.8% |
| ANTM | Buy | ANTHEM INC | $11,414,000 | +57.0% | 31,798 | +40.5% | 2.98% | +13.5% |
| EHC | Buy | ENCOMPASS HEALTH CORP | $10,958,000 | +81.3% | 133,801 | +83.0% | 2.86% | +31.1% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $9,835,000 | +290.9% | 310,649 | +472.9% | 2.56% | +182.7% |
| ABBV | Buy | ABBVIE INC | $9,521,000 | +5.1% | 87,982 | +4.1% | 2.48% | -24.0% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $8,952,000 | +39.9% | 709,360 | +4.1% | 2.33% | +1.2% |
| IVC | New | INVACARE CORP | $8,879,000 | – | 1,107,112 | +100.0% | 2.32% | – |
| MCK | New | MCKESSON CORP | $8,608,000 | – | 44,132 | +100.0% | 2.24% | – |
| BIO | New | BIO RAD LABS INCcl a | $8,444,000 | – | 14,784 | +100.0% | 2.20% | – |
| AZYO | Buy | AZIYO BIOLOGICS INC | $8,065,000 | +44.9% | 583,600 | +43.0% | 2.10% | +4.8% |
| SYNH | Buy | SYNEOS HEALTH INCcl a | $8,004,000 | +15.2% | 105,521 | +3.5% | 2.09% | -16.7% |
| PHAS | New | PHASEBIO PHARMACEUTICALS INC | $7,486,000 | – | 2,163,518 | +100.0% | 1.95% | – |
| ABC | Sell | AMERISOURCEBERGEN CORP | $7,406,000 | -3.3% | 62,722 | -19.9% | 1.93% | -30.1% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $7,203,000 | +19.8% | 438,933 | +51.1% | 1.88% | -13.4% |
| AVTR | Buy | AVANTOR INC | $6,973,000 | +27.2% | 241,016 | +23.7% | 1.82% | -8.0% |
| BSX | New | BOSTON SCIENTIFIC CORP | $6,134,000 | – | 158,702 | +100.0% | 1.60% | – |
| New | DARIOHEALTH CORP | $6,122,000 | – | 317,876 | +100.0% | 1.60% | – | |
| GDRX | Buy | GOODRX HLDGS INC | $5,325,000 | +70.6% | 136,480 | +76.4% | 1.39% | +23.3% |
| Sell | TRILLIUM THERAPEUTICS INC | $5,138,000 | -46.7% | 478,374 | -27.0% | 1.34% | -61.5% | |
| CNC | Buy | CENTENE CORP DEL | $4,892,000 | +112.7% | 76,551 | +99.8% | 1.28% | +53.8% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,862,000 | -16.3% | 915,711 | -15.1% | 1.27% | -39.5% |
| JNJ | Sell | JOHNSON & JOHNSON | $4,742,000 | -46.4% | 28,854 | -48.7% | 1.24% | -61.3% |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $4,515,000 | – | 1,339,835 | +100.0% | 1.18% | – |
| INSM | Buy | INSMED INC | $4,510,000 | +9.0% | 132,422 | +6.5% | 1.18% | -21.2% |
| SELB | Sell | SELECTA BIOSCIENCES INC | $4,125,000 | +37.5% | 911,706 | -8.0% | 1.08% | -0.6% |
| CALT | New | CALLIDITAS THERAPEUTICS ABsponsered ads | $3,923,000 | – | 142,323 | +100.0% | 1.02% | – |
| RGLS | New | REGULUS THERAPEUTICS INC | $3,707,000 | – | 2,376,557 | +100.0% | 0.97% | – |
| ALBO | Buy | ALBIREO PHARMA INC | $3,637,000 | +129.3% | 103,175 | +144.0% | 0.95% | +65.7% |
| MDVL | Buy | MEDAVAIL HOLDINGS INC | $3,217,000 | +236.9% | 229,767 | +262.1% | 0.84% | +143.9% |
| Buy | APTOSE BIOSCIENCES INC | $3,092,000 | +47.7% | 517,472 | +8.3% | 0.81% | +6.8% | |
| SEEL | New | SEELOS THERAPEUTICS INC | $3,052,000 | – | 611,624 | +100.0% | 0.80% | – |
| ANGO | Sell | ANGIODYNAMICS INC | $3,015,000 | +6.3% | 128,865 | -30.3% | 0.79% | -23.1% |
| ZTS | Buy | ZOETIS INCcl a | $2,782,000 | +32.5% | 17,668 | +39.2% | 0.72% | -4.2% |
| RCM | New | R1 RCM INC | $2,672,000 | – | 108,246 | +100.0% | 0.70% | – |
| AFMD | New | AFFIMED N V | $2,616,000 | – | 330,665 | +100.0% | 0.68% | – |
| DVA | New | DAVITA INC | $2,579,000 | – | 23,930 | +100.0% | 0.67% | – |
| OMI | Sell | OWENS & MINOR INC NEW | $2,406,000 | -56.5% | 64,012 | -68.7% | 0.63% | -68.6% |
| GMTX | New | GEMINI THERAPEUTICS INC | $2,302,000 | – | 169,876 | +100.0% | 0.60% | – |
| IMUX | Sell | IMMUNIC INC | $2,101,000 | -0.8% | 131,796 | -4.9% | 0.55% | -28.3% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $2,073,000 | – | 58,168 | +100.0% | 0.54% | – |
| HAE | New | HAEMONETICS CORP MASS | $1,681,000 | – | 15,139 | +100.0% | 0.44% | – |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $1,558,000 | -71.1% | 55,540 | -73.2% | 0.41% | -79.1% |
| XFOR | New | X4 PHARMACEUTICALS INC | $1,309,000 | – | 151,996 | +100.0% | 0.34% | – |
| BLU | New | BELLUS HEALTH INC NEW | $1,205,000 | – | 313,835 | +100.0% | 0.31% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $1,107,000 | -81.7% | 13,432 | -79.8% | 0.29% | -86.8% |
| FBRX | New | FORTE BIOSCIENCES INC | $946,000 | – | 27,591 | +100.0% | 0.25% | – |
| NVRO | New | NEVRO CORP | $899,000 | – | 6,442 | +100.0% | 0.23% | – |
| STRM | New | STREAMLINE HEALTH SOLUTIONS | $796,000 | – | 388,417 | +100.0% | 0.21% | – |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $585,000 | – | 17,777 | +100.0% | 0.15% | – |
| TARS | New | TARSUS PHARMACEUTICALS INC | $456,000 | – | 14,143 | +100.0% | 0.12% | – |
| LBPH | New | LONGBOARD PHARMACEUTICALS IN | $267,000 | – | 16,327 | +100.0% | 0.07% | – |
| FSTX | Exit | F-STAR THERAPEUTICS INC | $0 | – | -20,445 | -100.0% | -0.07% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -45,682 | -100.0% | -0.12% | – |
| AKTX | Exit | AKARI THERAPEUTICS PLCsponsored adr | $0 | – | -206,561 | -100.0% | -0.14% | – |
| Exit | SENSEONICS HLDGS INCnote 5.250% 2/0 | $0 | – | -1,500,000 | -100.0% | -0.23% | – | |
| PNTG | Exit | PENNANT GROUP INC | $0 | – | -18,227 | -100.0% | -0.38% | – |
| QTNT | Exit | QUOTIENT LTD | $0 | – | -226,593 | -100.0% | -0.43% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -14,919 | -100.0% | -0.44% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -151,820 | -100.0% | -0.66% | – |
| EUCRU | Exit | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | -195,000 | -100.0% | -0.75% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -133,648 | -100.0% | -0.85% | – |
| PRAH | Exit | PRA HEALTH SCIENCES INC | $0 | – | -21,590 | -100.0% | -0.98% | – |
| HUM | Exit | HUMANA INC | $0 | – | -7,504 | -100.0% | -1.11% | – |
| MBIO | Exit | MUSTANG BIO INC | $0 | – | -892,027 | -100.0% | -1.22% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -172,047 | -100.0% | -1.35% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -28,378 | -100.0% | -1.74% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -25,085 | -100.0% | -1.88% | – |
| SNN | Exit | SMITH & NEPHEW PLCspdn adr new | $0 | – | -179,138 | -100.0% | -2.72% | – |
| SIBN | Exit | SI BONE INC | $0 | – | -254,907 | -100.0% | -2.75% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -2,240,421 | -100.0% | -14.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.